Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

Putting pregnant women who develop diabetes on a reduced calorie diet could help them avoid the need for insulin injections ...

Insulet reported a higher-than-expected profit in the fourth quarter on Thursday, driven by strong demand for its wearable insulin pumps. The company produces and sells Omnipod, an automated insulin ...

Putting pregnant women who develop diabetes on a reduced calorie diet could help them avoid the need for insulin injections, ...

People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With ...

Merilog’s approval comes as the insulin space has over the past year suffered several setbacks, including strong calls for ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

FDA approves third insulin biosimilar Merilog to ease U.S. supply shortage FDAs latest insulin biosimilar approval aims to mitigate ongoing supply challenges in the U.S.

Patients visiting clinics across multiple hospitals are facing severe difficulties due to an insufficient supply of insulin, chairman of the Doctors’ Trade Union Alliance for Medical and Civil Rights, ...